Advertisement

First Device for Migraine Treatment Approved — Physician’s First Watch

Medical News |
December 16, 2013

First Device for Migraine Treatment Approved

By Kristin J. Kelley

The FDA has approved the first device to relieve migraine pain in patients aged 18 and older. The Cerena Transcranial Magnetic Stimulator is indicated for migraine with aura and is used after the onset of pain.

Patients hold the device to the back of their heads and press a button, which releases a pulse of magnetic energy that stimulates the occipital cortex. In a randomized study, 38% of patients with moderate-to-strong migraine headaches preceded by aura were pain-free 2 hours after using the device, compared with 17% of controls.

Single reports of aphasia, sinusitis, and vertigo were among the adverse reactions. The device may cause dizziness. Additionally, says the FDA, it should not be used by those with a family or personal history of seizures; implanted medical devices (e.g., pacemaker); or metals in the head, neck, or upper body.

Reader Comments (1)

VALERIE

Have you heard of this new device. It sounds very new
and may not yet be proven.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement